HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

McCain-Dorgan NDI Guidance, Steroid Provisions In Senate Food Safety Bill

This article was originally published in The Tan Sheet

Executive Summary

Requirements that benefit dietary supplement manufacturing and that gained Sen. John McCain's support after he initially proposed legislation considered a threat to the industry are part of the food safety reform bill pending in the Senate.

You may also be interested in...



NDI Guidance Could Heighten Need To Protect DSHEA’s Intent – Harkin

Sen. Tom Harkin calls on dietary supplement industry firms to “be vigilant" in protecting their rights under the Dietary Supplement Health and Education Act once FDA publishes the new dietary ingredient notification guidance.

Low NDI Notice Compliance Sets Stage For Enforcement – FDA’s Fabricant

The volume of noncompliant supplement ingredients on the market likely will prompt an uptick in enforcement after FDA releases its NDI notification guidance, which will draw attention to the problem, dietary supplement program chief Daniel Fabricant says.

Supplement Ingredient Suppliers Should Prepare For Food HACCP Regs

The exemption Congress gave dietary supplement manufacturers from the hazard analysis and critical control points regulations for food products does not extend to ingredient suppliers, experts say.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS135503

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel